Synthetic biology represents an expanding frontier of innovation that promises to revolutionize solutions for agriculture, materials, energy, and healthcare. By engineering biology, scientists can program microbes to produce valuable compounds, sense signals, assemble structures, and even make expensive medicines for example Insulin is reduced to 3 dollars per vial. Synthetic biology tools, data, and talent continue advancing in India, synthetic biology approaches are poised to disrupt a widening range of industries globally, and we have all the right ingredients to start the revolution from India.
This thesis explores the emerging landscape, key trends, and notable startups across synthetic biology domains with a focus on investing in the Indian ecosystem. I will access the spectrum of synthetic biology investment opportunities, and my understanding on how India can leverage its strength to pioneer the next set of billion-dollar companies.
NVEDIA CEO Jensen Huang about future of humankind.
NVEDIA CEO Jensen Huang about future of humankind.
Synthetic biology represents the design and construction of novel biological systems. It expands on genetic engineering by focusing on whole systems and pathways instead of individual genes. Leveraging advances in automation, AI and biological understanding, synthetic biologists engineer existing organisms or even design new ones from scratch to perform useful functions.
Potential synthetic biology applications span:
The global market for synthetic biology was 13.4 billion USD in 2022 in US and is expected to hit around USD 116.04 billion by 2032 (Refer Fig.1), poised to grow at a CAGR of 28.3% between 2023 and 2032
Fig. 1 US synthetic biology market. Source:grandviewreaserch
Multiple discoveries and breakthroughs have made synthetic biology poised for VC funds by changing the timelines from 10 years to 3 years. Here, let me discuss multiple technology trends that have exponentially increased what synthetic biologists can accomplish with lower iteration time and cost.
Advances in synthetic DNA synthesis and assembly methods allow designing, building and testing novel genetic constructs faster than ever before. For example, DNA synthesis costs have fallen from $300,000 per gene in 2003 to just $0.15 per base pair now.
This democratizes access and enables rapid iteration. Design-build-test-learn cycles continue compressing, similar to software development